A new generation of camouflaged photovoltaic modules is under development through a collaboration between Praxis Labs (Praxis) and researchers from the University of Adelaide’s Institute for Photonics and Advanced Sensing (IPAS) – with critical fabrication and technical support provided by the Australian National Fabrication Facility (ANFF). The project, supported by the Defence Trailblazer, aims to […]
Strengthening defence with hidden power Read More »
OOXii has developed a Vision Kit containing everything a basic health worker needs to test vision and assemble affordable, customised glasses on the spot in remote and low-resource communities. One billion people worldwide experience impaired vision simply because they lack access to affordable glasses. Described by the World Health Organization as a global health crisis,
Clear vision for the globe Read More »
Introducing the Ketowhistle: a non-invasive, breath-based sensor for easy, real-time ketone monitoring, revolutionising diabetes management. A sharp jab to your fingertip brings a moment of pain. A drop of blood emerges, which can be a bit unsettling. You put the drop of blood on a strip and wait for the results. Finger prick tests are
Simply breathtaking Read More »
Misti’s acoustic nebuliser mask offers child-friendly, efficient respiratory relief, reducing hospital visits and waiting times. When a child’s sniffles turn into coughing, then hacking, their condition worsens. It could be minor, or something more. As their discomfort grows, so does their parents’ stress, leading to a visit to the GP for relief and peace of
Sounding better already Read More »
Breakthroughs with every beat Biotech startup Dynomics creates scalable, authentic cardiac organoids to unlock the root causes of heart failure. Cardiovascular disease remains the leading cause of death worldwide. In Australia alone, each day 157 individuals experience an acute coronary event, and 112 suffer a stroke. Current heart failure treatments focus on the aftermath, involving
Breakthroughs with every beat Read More »
Seeing our cities in a new light Interromate’s robust optical fibre sensors provide the right ‘eyes’ to monitor the health of urban infrastructure threatened by harsh environments. Urban life in Australia is a focus of public discussion, especially around sustainability and population distribution. With 67% of Australians living in capital cities, these areas often feel
Seeing our cities in a new light Read More »
Co-designing the future of MedTech ANFF’s Designer in Residence program fosters human-centred design, empowering startups to create user-driven, impactful technological solutions. Innovation alone does not guarantee a product’s success. Even groundbreaking technologies can fail if they overlook everyday consumer needs. High-profile failures like Google Health Records, Segway PT and Evian’s Water Bra illustrate how neglecting
Co-designing the Future of MedTech Read More »
Melbourne healthcare startup Haemograph awarded ANFF-C Gate 2 funding ANFF-C is excited to announce that Haemograph has been awarded Gate 2 pre-seed funding to aid in the commercialisation of its novel blood rheometer. Haemograph is a Melbourne-based start-up revolutionising healthcare with their innovative portable, point-of-care, blood coagulation rheometer. The cutting-edge device measures the viscoelastic properties
Melbourne Medtech startup Haemograph awarded ANFF-C funding Read More »
ANFF-C Manufacturing For Startups Webinar Series – Legal Due Diligence: What is it and how do I prepare for it? 💡 Do you have a great tech idea or product that you are trying to get to market? 💡 For startups, due diligence is a rigorous process that determines whether a venture capital fund or
ANFF-C Seminar: Legal Due Diligence for Startups Read More »
Micro-X Founder Peter Rowland will present the 1st webinar of 2024 for ANFF-C’s ‘Manufacturing for Startups’ seminar series: ‘Funding a start-up Multinational.’
ANFF-C Seminar: Funding a start-up Multinational Read More »
2024 Showcase highlights ANFF connections with industry and commercialisation ANFF facilities provide the critical infrastructure and expertise required to accelerate and de-risk technology development. The availability of these experts and capabilities, including tools for initial prototyping and complete, industry-relevant process trains, adds immense value to early innovations. ANFF and ANFF-C enable researchers to develop new
2024 Showcase highlights ANFF connections with industry and commercialisation Read More »
ANFF-C supports VividWhite in bringing a novel glaucoma treatment device to market ANFF-C is excited to announce that VividWhite has been awarded Gate 2 pre-seed funding to aid in the commercialisation of VividFlo, a revolutionary microfluidic medical device that provides a novel approach to glaucoma treatment. Glaucoma is the leading cause of irreversible blindness worldwide,
ANFF-C supports VividWhite in bringing a novel glaucoma treatment device to market Read More »
ANFF acknowledges the Traditional Owners of Country throughout Australia and pays respect to Elders past and present. We also acknowledge the First Nations people of Australia as engineers and scientists in whose tradition and footsteps we aspire to follow.
